Á lódáil...
Biosimilars in the management of chronic inflammatory diseases: The Dutch experience
These days, the use of biosimilars for the treatment of bio-naive patients is well established. However, the transition of patients being treated with a bio-originator to its biosimilar is still a topic of discussion. The main issue is which approach to use when initiating the non-medical transition...
Na minha lista:
| Foilsithe in: | Mediterr J Rheumatol |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
The Mediterranean Journal of Rheumatology (MJR)
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7280871/ https://ncbi.nlm.nih.gov/pubmed/32524082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.30.1.76 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|